Holen Sie sich die Stockscreener-App
7.26
4.01%
0.28
Schlusskurs vom Vortag:
$6.98
Offen:
$6.99
24-Stunden-Volumen:
4,300
Relative Volume:
0.44
Marktkapitalisierung:
$20.96M
Einnahmen:
$20.92M
Nettoeinkommen (Verlust:
$-25.87M
KGV:
-0.3689
EPS:
-19.6815
Netto-Cashflow:
$-15.02M
1W Leistung:
+0.00%
1M Leistung:
-5.53%
6M Leistung:
+19.80%
1J Leistung:
+8.23%
1-Tages-Spanne:
$6.99
$7.40
1-Wochen-Bereich:
$6.98
$7.40
52-Wochen-Spanne:
$4.14
$10.56
Lifeward Ltd Stock (LFWD) Company Profile
Firmenname
Lifeward Ltd
Sektor
Branche
Telefon
15082511154
Adresse
2 CABOT ROAD, HUDSON
Compare LFWD vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFWD
Lifeward Ltd
|
7.40 | 20.96M | 20.92M | -25.87M | -15.02M | -19.68 |
ABT
Abbott Laboratories
|
106.02 | 182.59B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
92.81 | 118.18B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
273.46 | 106.03B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.59 | 65.19B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.44 | 49.99B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-10 | Eingeleitet | Laidlaw | Buy |
| 2017-04-03 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2016-12-16 | Eingeleitet | Oppenheimer | Outperform |
| 2016-07-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-05-22 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | Bestätigt | Barclays | Equal Weight |
| 2014-10-07 | Eingeleitet | Barclays | Equal Weight |
Alle ansehen
Lifeward Ltd Aktie (LFWD) Neueste Nachrichten
Lifeward Highlights Growth Strategy in New Investor Presentation - TipRanks
Lifeward Reports Q2 Revenue Up 15% to $6.6 Million - Minichart
Lifeward posts investor presentation outlining commercial progress, $21.8M LTM revenue and Oramed-funded partnership - TradingView
Oramed backs exoskeleton maker Lifeward (NASDAQ: LFWD) in milestone-based funding deal - Stock Titan
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy - GlobeNewswire
Lifeward Announces Major CEO and CFO Leadership Changes - The Globe and Mail
Lifeward names Josh Hexter interim CEO, Rami Aviram as CFO By Investing.com - Investing.com Canada
LFWD Looks 11.8% Overvalued on GF Value™ - GuruFocus
Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer - The Manila Times
Lifeward (NASDAQ: LFWD) CEO departs as board taps interim chief - Stock Titan
Lifeward Ltd Announces Appointment of Rami Aviram as Chief Financial Officer, Effective November 1, 2026 - marketscreener.com
Lifeward Ltd. (LFWD) insider records new stock transaction - Stock Titan
Lifeward (LFWD) Results Versus Estimates: The Available Earnings Metric Delivers a Miss at the Close; Session Move - vinanet.vn
Lifeward (LFWD) Session: Climbs 1.81% to $7.32 in the Latest Reading; Range View: Price Remains Between $6.95 Support and $7.69 Resistance at the CloseSystematic Flow - vinanet.vn
H.C. Wainwright reiterates Lifeward stock rating on revenue growth By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Lifeward stock rating on revenue growth - Investing.com
Lifeward (LFWD) adds new board chair as Kidron exits board - Stock Titan
Lifeward Q2 revenue rises 16% to $6.6 million - grafa.com
Lifeward earnings missed by $0.07, revenue topped estimates - Investing.com Canada
Lifeward Ltd. Announces Resignation of Almog Adar from Chief Financial Officer, Effective September 30, 2026 - marketscreener.com
Lifeward Ltd. Announces Stepping Down of Board Members, Effective August 13, 2026 - marketscreener.com
Lifeward Q2 revenue beats estimates; adjusted EPS misses consensus - scanx.trade
Lifeward Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Lifeward (LFWD) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Lifeward Ltd. 2026: Revenue $6.62M, Net income ($11.52M), EPS ($4.12) — 10-Q Summary - TradingView
Lifeward (NASDAQ: LFWD) doubles H1 loss and warns on going concern as it adds debt - Stock Titan
Is Lifeward Ltd (LFWD) Positioned for Growth After Q2 Earnings? - GuruFocus
Lifeward: Q2 Earnings Snapshot - KING5.com
Form 8K Lifeward Ltd. For: 14 August By Investing.com - Investing.com Nigeria
Form 8K Lifeward Ltd. For: 14 August - Investing.com India
Lifeward Ltd Q2 revenue up 16% on higher ReWalk Personal exoskeleton sales - TradingView
Lifeward Revenue Rises 16% to $6.6 Million in Second Quarter 2026 - Quiver Quantitative
Lifeward (LFWD) grows Q2 2026 revenue 16% as net loss deepens on non-cash charges - Stock Titan
Lifeward Reports 16% Second-Quarter Revenue Growth and Strengthened Balance Sheet Amid Commercial Expansion - quiverquant.com
Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth - The Manila Times
Lifeward’s CFO to Depart Sept. 30 as Three Directors Step Down - Stock Titan
Lifeward (LFWD) Advances 1.87% to $7.89, Holding Above Key SupportSafe Entry Stocks - vinanet.vn
Earnings To Watch: Lifeward Ltd (LFWD) Q2 2026 -- GF Value Sees 185% Upside - Yahoo Finance
LFWD Q1 2026 Earnings: Deep EPS Miss Raises Concerns Despite Share UptickTrough Earnings Signal - vinanet.vn
Lifeward Ltd expected to post a loss of $1.34 a shareEarnings Preview - TradingView
LFWD Q1 2026 Earnings: Wider-than-Expected Loss Signals Rising Cost and Execution PressuresDividend Earnings Report - vinanet.vn
Lifeward Ltd. SEC Filing (Aug 11, 2026) - Stock Titan
Oramed Pharmaceuticals (NASDAQ: ORMP) pivots to investment model with $116M profit - Stock Titan
Lifeward Ltd (LFWD) Stock News Today - TradingKey
Lifeward to report Q2 2026 financial results on August 14, no conference call planned - Pluang
Lifeward Ltd (LFWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Lifeward Out With Q2 Numbers - Baystreet.ca
Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026 - GlobeNewswire
Lifeward Ltd. (LFWD) Holds Ground Near $7.28 as Shares Trade Within Narrow RangeRatio Spread Trade - dars.gov.et
Lifeward Launches ReWalk 7 Pilot Program with Ottobock Care to Expand U.S. Patient Access - Quiver Quantitative
A six-month pilot aims to bring Lifeward's ReWalk 7 to more patients - Stock Titan
Finanzdaten der Lifeward Ltd-Aktie (LFWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.72%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):